3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Neoplasms
1
Gastrointestinal Neoplasms
1
Interventions
Oxaliplatin
296
Fluorouracil
272
Bevacizumab
236
Gemcitabine
235
Leucovorin
212
Capecitabine
204
pembrolizumab
202
Nivolumab
156
Irinotecan
156
Cisplatin
150
Specimen Handling
143
Magnetic Resonance Spectroscopy
130
130-nm albumin-bound paclitaxel
115
Paclitaxel
109
durvalumab
104
Cetuximab
102
Radiotherapy
96
atezolizumab
92
Biopsy
92
Drug Therapy
91
Albumin-Bound Paclitaxel
78
tislelizumab
77
Taxes
73
lenvatinib
68
Folfox protocol
68
Carboplatin
66
Blood Specimen Collection
61
regorafenib
60
trifluridine tipiracil drug combination
53
Ipilimumab
52
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glutamyl Aminopeptidase
×
Gastrointestinal
×
1 year
×
Clear all
NCT05441163
2025-06-24
ProActIF-01
Institut Curie
Phase NA
Recruiting
50 enrolled